Advanced search
Publication Cover
Patient Preference and Adherence Volume 10, 2016 - Issue
Submit an article Journal homepage
190
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Twenty-four-week effects of liraglutide on body composition, adherence to appetite, and lipid profile in overweight and obese patients with type 2 diabetes mellitus

Mariangela Rondanelli1 Endocrinology and Nutrition Unit, Section of Human Nutrition, Department of Public Health, Experimental and Forensic Medicine, Agency for Elderly People Services, Santa Margherita Hospital, University of Pavia, Pavia, Italy
,
Simone Perna1 Endocrinology and Nutrition Unit, Section of Human Nutrition, Department of Public Health, Experimental and Forensic Medicine, Agency for Elderly People Services, Santa Margherita Hospital, University of Pavia, Pavia, ItalyCorrespondence[email protected]
,
Paolo Astrone2 Section of Geriatrics and Gerontology, Department of Internal Medicine, Agency for Elderly People Services, Santa Margherita Hospital, University of Pavia, Pavia, Italy
,
Annalisa Grugnetti2 Section of Geriatrics and Gerontology, Department of Internal Medicine, Agency for Elderly People Services, Santa Margherita Hospital, University of Pavia, Pavia, Italy
,
Sebastiano Bruno Solerte2 Section of Geriatrics and Gerontology, Department of Internal Medicine, Agency for Elderly People Services, Santa Margherita Hospital, University of Pavia, Pavia, Italy
&
Davide Guido3 Medical and Genomics Statistics Unit, Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy;4 Biostatistics and Clinical Epidemiology Unit, Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy
Pages 407-413 | Published online: 24 Mar 2016

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Alanoud Aladel, Jamilah Aljaouni & Reem Basaad. (2023) Effect of Liraglutide on Fat Mass Percentage Among Overweight and Obese Adults with Type 2 Diabetes: A Systematic Review. Diabetes, Metabolic Syndrome and Obesity 16, pages 3381-3391.
Read now
Simone Perna, Manuela Mainardi, Paolo Astrone, Carlotta Gozzer, Anna Biava, Ruben Bacchio, Daniele Spadaccini, Sebastiano Bruno Solerte & Mariangela Rondanelli. (2018) 12-month effects of incretins versus SGLT2-Inhibitors on cognitive performance and metabolic profile. A randomized clinical trial in the elderly with Type-2 diabetes mellitus. Clinical Pharmacology: Advances and Applications 10, pages 141-151.
Read now

Articles from other publishers (7)

Jeonghoon Ha, Jin Yu, Joonyub Lee & Hun-Sung Kim. (2022) The effects and side effects of liraglutide as a treatment for obesity. Cardiovascular Prevention and Pharmacotherapy 4:4, pages 142-148.
Crossref
Dongni Yu, Mingzhu Zou, Qi Pan, Yan Song, Miao Li, Xianbo Zhang, Yan Zhou, Xiaoxia Wang & Lixin Guo. (2022) Effects of liraglutide or lifestyle interventions combined with other antidiabetic drugs on abdominal fat distribution in people with obesity and type 2 diabetes mellitus evaluated by the energy spectrum ct: A prospective randomized controlled study. Frontiers in Endocrinology 13.
Crossref
Aishah A Ekhzaimy, Afshan Masood, Hicham Benabdelkamel, Tasnem Elhassan, Mohthash Musambil & Assim A Alfadda. (2022) Plasma proteomics reveals an improved cardio-metabolic profile in patients with type 2 diabetes post-liraglutide treatment. Diabetes and Vascular Disease Research 19:3, pages 147916412210943.
Crossref
Ying Li, Xuewei Liu, Guangsen Li & Ping Zhang. (2020) Effect of liraglutide on epicardial adipose tissue thickness with echocardiography in patients with obese type 2 diabetes mellitus. International Journal of Diabetes in Developing Countries 40:4, pages 500-506.
Crossref
Natia Peradze, Olivia M. Farr, Nikolaos Perakakis, Iolanda Lázaro, Aleix Sala-Vila & Christos S. Mantzoros. (2019) Short-term treatment with high dose liraglutide improves lipid and lipoprotein profile and changes hormonal mediators of lipid metabolism in obese patients with no overt type 2 diabetes mellitus: a randomized, placebo-controlled, cross-over, double-blind clinical trial. Cardiovascular Diabetology 18:1.
Crossref
Yun Wan, Xi Bao, Jiabao Huang, Xiangyu Zhang, Wenjuan Liu, Qiaoli Cui, Dongdong Jiang, Zhihong Wang, Rui Liu & Qinghua Wang. (2017) Novel GLP-1 Analog Supaglutide Reduces HFD-Induced Obesity Associated with Increased Ucp-1 in White Adipose Tissue in Mice. Frontiers in Physiology 8.
Crossref
Funda Datli Yakaryılmaz & Zeynel Abidin Öztürk. (2017) Treatment of type 2 diabetes mellitus in the elderly. World Journal of Diabetes 8:6, pages 278.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.